Cardiac remodelling hinders activation of cyclooxygenase-2, diminishing protection by delayed pharmacological preconditioning:: role of HIF1α and CREB

被引:21
作者
Feng, Jianhua [1 ,2 ]
Lucchinetti, Eliana [1 ,2 ]
Fischer, Gregor [3 ]
Zhu, Min [1 ,2 ]
Zaugg, Kathrin [4 ]
Schaub, Marcus C. [5 ]
Zaugg, Michael [1 ,2 ]
机构
[1] Univ Zurich Hosp, Inst Anesthesiol, Clin Res Ctr, Cardiovasc Anesthesia Res Lab,E HOF, CH-8091 Zurich, Switzerland
[2] Univ Zurich, Ctr Integrat Human Physiol, Zurich, Switzerland
[3] Univ Zurich, Inst Lab Anim Sci, Zurich, Switzerland
[4] Univ Zurich Hosp, Dept Radiat Oncol, CH-8091 Zurich, Switzerland
[5] Univ Zurich, Inst Pharmacol & Toxicol, Zurich, Switzerland
关键词
remodelling; preconditioning; ischaemia/reperfusion; cyclooxygenase; NSAIDs;
D O I
10.1093/cvr/cvn016
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
Aims We tested whether delayed pharmacologic preconditioning elicited by isoflurane is protective in infarct-remodelled hearts. Methods and results Mate Wistar rats were treated with the preconditioning drug isoflurane 6 weeks after permanent ligation of the left anterior descending coronary artery. Twenty-four and 48 h later, hearts were perfused on the Langendorff system and treated with cyclooxygenase-2 or 12-lipoxygenase inhibitors before exposure to 40 min of ischaemia followed by 90 min of reperfusion. Infarct size was determined by triphenyttetrazolium chloride staining and lactate dehydrogenase release. Cyclooxygenase-2 expression and activity were measured by Western blotting and colorimetric assay. Nuclear translocation of cyclooxygenase-2-inducing transcription factors HIF1 alpha, CREB, STAT3, and NF kappa B was determined. Post-infarct, remodelled hearts exhibit alterations in cellular signalling, time course and extent of isoflurane-induced late protection. While remodelled, preconditioned hearts exhibited protection exclusively at 24 h, healthy hearts showed sustained protection for up to 48 h, which correlated with cyctooxygenase-2 protein expression and enzymatic activity. The cyclooxygenase-2 inhibitors celecoxib and NS-398, but not the 12-lipoxygenase inhibitor cinnamyl-3,4-dihydroxycyanocinnamate, abolished delayed protection in both healthy and remodelled hearts, identifying cyclooxygenase-2 as a key mediator of late protection in both models. Isoflurane induced nuclear translocation of HIF1 alpha in all hearts, but CREB was exclusively activated in healthy but not remodelled myocardium, which expressed higher levels of the CREB antagonist ICER. Delayed protection by isoflurane in remodelled hearts was more vulnerable to inhibition by celecoxib. Conclusion Isoflurane failed to mobilize cyclooxygenase-2-inducing CREB in ICER-overexpressing, remodelled hearts, which was associated with a shortening of the second window of protection.
引用
收藏
页码:98 / 107
页数:10
相关论文
共 49 条
[1]
Cyclooxygenase-2 mediates ischemic, anesthetic, and pharmacologic preconditioning in vivo [J].
Aicindor, D ;
Krolikowski, JG ;
Pagel, PS ;
Warltier, DC ;
Kersten, JR .
ANESTHESIOLOGY, 2004, 100 (03) :547-554
[2]
The late phase of preconditioning [J].
Bolli, R .
CIRCULATION RESEARCH, 2000, 87 (11) :972-983
[3]
Role of endothelial nitric oxide synthase as a trigger and mediator of isoflurane-induced delayed preconditioning in rabbit myocardium [J].
Chiari, PC ;
Bienengraeber, MW ;
Weihrauch, D ;
Krolikowski, JG ;
Kersten, JR ;
Warltier, DC ;
Pagel, PS .
ANESTHESIOLOGY, 2005, 103 (01) :74-83
[4]
Intravenous emulsified halogenated anesthetics produce acute and delayed preconditioning against myocardial infarction in rabbits [J].
Chiari, PC ;
Pagel, PS ;
Tanaka, K ;
Krolikowski, JG ;
Ludwig, LM ;
Trillo, RA ;
Puri, N ;
Kersten, JR ;
Warltier, DC .
ANESTHESIOLOGY, 2004, 101 (05) :1160-1166
[5]
Clinical pharmacokinetics and pharmacodynamics of celecoxib - A selective cyclo-oxygenase-2 inhibitor [J].
Davies, NM ;
McLachlan, AJ ;
Day, RO ;
Williams, KM .
CLINICAL PHARMACOKINETICS, 2000, 38 (03) :225-242
[6]
Protein kinase cascades in the regulation of cardiac hypertrophy [J].
Dorn, GW ;
Force, T .
JOURNAL OF CLINICAL INVESTIGATION, 2005, 115 (03) :527-537
[7]
Diazoxide-mediated preconditioning against apoptosis involves activation of cAMP-response element-binding protein (CREB) and NFκB [J].
Eliseev, RA ;
VanWinkle, B ;
Rosier, RN ;
Gunter, TE .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (45) :46748-46754
[8]
Infarct-remodeled myocardium is receptive to protection by isoflurane postconditioning - Role of protein kinase B/Akt signaling [J].
Feng, JH ;
Fischer, G ;
Lucchinetti, E ;
Zhu, M ;
Bestmann, L ;
Jegger, D ;
Arras, M ;
Pasch, T ;
Perriard, JC ;
Schaub, MC ;
Zaugg, M .
ANESTHESIOLOGY, 2006, 104 (05) :1004-1014
[9]
Failure to precondition pathological human myocardium [J].
Ghosh, S ;
Standen, NB ;
Galiñanes, M .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 37 (03) :711-718
[10]
Biological basis for the cardiovascular consequences of COX-2 inhibition: therapeutic challenges and opportunities [J].
Grosser, T ;
Fries, S ;
FitzGerald, GA .
JOURNAL OF CLINICAL INVESTIGATION, 2006, 116 (01) :4-15